This is a preview of subscription content, log in via an institution to check access.
Reference
Lucatelli MV, et al. Related risk of biologic drugs for crohn's disease in pregnancy: A case report and revision of the literature. European Journal of Hospital Pharmacy - Science and Practice 27 (Suppl.): A179 abstr. 5PSQ-064, Mar 2020. Available from: URL: http://doi.org/10.1136/ejhpharm-2020-eahpconf.381 [abstract]
Rights and permissions
About this article
Cite this article
Adalimumab. Reactions Weekly 1829, 18 (2020). https://doi.org/10.1007/s40278-020-85608-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-85608-7